ITCI
Janus Henderson Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-133,352
| Closed | -$17.6M | – | 2535 |
|
|
2025
Q1 | $17.6M | Buy |
133,352
+90,623
| +212% | +$11.9M | 0.01% | 597 |
|
|
2024
Q4 | $3.57M | Hold |
42,729
| – | – | ﹤0.01% | 1040 |
|
|
2024
Q3 | $3.13M | Buy |
42,729
+2,568
| +6% | +$188K | ﹤0.01% | 1089 |
|
|
2024
Q2 | $2.75M | Sell |
40,161
-361,196
| -90% | -$24.7M | ﹤0.01% | 1108 |
|
|
2024
Q1 | $27.8M | Sell |
401,357
-87,780
| -18% | -$6.07M | 0.02% | 506 |
|
|
2023
Q4 | $35M | Buy |
489,137
+8,864
| +2% | +$635K | 0.02% | 444 |
|
|
2023
Q3 | $25M | Sell |
480,273
-130,642
| -21% | -$6.8M | 0.02% | 493 |
|
|
2023
Q2 | $38.7M | Sell |
610,915
-163,625
| -21% | -$10.4M | 0.02% | 441 |
|
|
2023
Q1 | $41.9M | Buy |
774,540
+487,851
| +170% | +$26.4M | 0.03% | 416 |
|
|
2022
Q4 | $15.2M | Sell |
286,689
-166,793
| -37% | -$8.82M | 0.01% | 621 |
|
|
2022
Q3 | $21.1M | Buy |
453,482
+265,431
| +141% | +$12.3M | 0.01% | 662 |
|
|
2022
Q2 | $10.7M | Buy |
188,051
+61,050
| +48% | +$3.48M | 0.01% | 672 |
|
|
2022
Q1 | $7.77M | Sell |
127,001
-20,865
| -14% | -$1.28M | ﹤0.01% | 928 |
|
|
2021
Q4 | $7.73M | Buy |
147,866
+1,701
| +1% | +$88.9K | ﹤0.01% | 958 |
|
|
2021
Q3 | $5.45M | Buy |
146,165
+14,080
| +11% | +$525K | ﹤0.01% | 1036 |
|
|
2021
Q2 | $5.39M | Buy |
132,085
+14,862
| +13% | +$607K | ﹤0.01% | 1046 |
|
|
2021
Q1 | $3.98M | Buy |
117,223
+70,440
| +151% | +$2.39M | ﹤0.01% | 1048 |
|
|
2020
Q4 | $1.49M | Buy |
+46,783
| New | +$1.49M | ﹤0.01% | 1166 |
|
|
2017
Q4 | – | Sell |
-35,000
| Closed | -$552K | – | 1349 |
|
|
2017
Q3 | $552K | Hold |
35,000
| – | – | ﹤0.01% | 1230 |
|
|
2017
Q2 | $435K | Buy |
+35,000
| New | +$435K | ﹤0.01% | 1245 |
|